Explore the innovative approach of Carecam, reshaping the future of therapeutics with their advanced digital mobility biomarker technology. In this enlightening talk at the SuperAI Singapore 2025, Ramanpreet Pahwa, CTO of Carecam, presents the Genesis Startup Competition Pitch, where he outlines how their proprietary 3D gait application is revolutionizing mobility assessments for clinical care.

​

Originating from A*STAR Singapore’s national R&D lab, Carecam has made significant strides since its establishment in 2022. With over $3 million secured in funding and regulatory approvals from both US FDA and Singapore's HSA, Carecam is poised to make a substantial impact in the global market. The company’s cutting-edge technology transforms an iPad into a comprehensive tool that provides detailed mobility assessments in minutes, a stark contrast to traditional methods requiring complex and costly motion capture labs.

​

Raman emphasizes the global challenge of human impairments, affecting over 180 million people across various conditions such as frailty, neurological diseases, and orthopedic surgeries. Carecam’s solution offers clinical-grade, cost-effective, rapid assessments, making it an invaluable asset to healthcare professionals, offering predictive insights and intelligent feedback.

​

Delve into the impressive capabilities of Carecam’s platform, built on advanced edge-optimized AI, trained on proprietary data sets to ensure highly precise and accurate diagnostic results. As Carecam seeks to expand its reach with a $3 million investment target, the talk provides insights into their strategic go-to-market plans and future aspirations in integrating their technology across major healthcare systems.

​

Ensure you don't miss updates and more insightful content from the conference by liking this video, sharing your thoughts in the comments, and subscribing to our channel.